Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2407508
Max Phase: Preclinical
Molecular Formula: C45H70N12O15
Molecular Weight: 1019.12
Molecule Type: Unknown
Associated Items:
ID: ALA2407508
Max Phase: Preclinical
Molecular Formula: C45H70N12O15
Molecular Weight: 1019.12
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCNC(=O)[C@@H]1CC(=O)N[C@H](CO)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1
Standard InChI: InChI=1S/C45H70N12O15/c1-2-3-4-5-6-7-8-9-10-11-16-49-39(66)31-21-37(64)52-32(23-58)44(71)53-27(17-25-12-14-26(60)15-13-25)41(68)54-28(18-34(46)61)40(67)50-22-38(65)51-29(19-35(47)62)42(69)57-33(24-59)45(72)55-30(20-36(48)63)43(70)56-31/h12-15,27-33,58-60H,2-11,16-24H2,1H3,(H2,46,61)(H2,47,62)(H2,48,63)(H,49,66)(H,50,67)(H,51,65)(H,52,64)(H,53,71)(H,54,68)(H,55,72)(H,56,70)(H,57,69)/t27-,28-,29+,30+,31+,32-,33+/m1/s1
Standard InChI Key: MASOKCCEVQELSY-YGRYCGGZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1019.12 | Molecular Weight (Monoisotopic): 1018.5084 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konno H, Otsuki Y, Matsuzaki K, Nosaka K.. (2013) Synthesis and antifungal activities of cyclic octa-lipopeptide burkholdine analogues., 23 (14): [PMID:23769641] [10.1016/j.bmcl.2013.04.091] |
2. Konno H, Abumi K, Sasaki Y, Yano S, Nosaka K.. (2015) Structure activity relationship study of burkholdine analogues toward simple antifungal agents., 25 (16): [PMID:26077490] [10.1016/j.bmcl.2015.05.088] |
Source(1):